From 4–5 July, the EUDA is hosting its inaugural Management Board meeting, chaired by Dr Franz Pietsch (Austria). This closed event will bring together for the first time the formally nominated Board members to take key institutional decisions linked to the new EUDA regulation.
The Board will adopt its rules of procedure and elect members to the Executive Board and Budget Committee.
It will also appoint members to the EUDA Scientific Committee and approve a list of experts for risk assessments of new psychoactive substances.
A list of EUDA national focal points (and their heads) and of national representative laboratories appointed to the EUDA network of forensic and toxicological laboratories will also be presented to the Board.
On 5 July, the meeting will be extended to include high-level representatives from candidate countries and potential candidates to the EU, as well as non-EU countries with which the EUDA collaborates. Executive Directors of other EU agencies will also attend. Geostrategic discussions will focus on international cooperation and emerging drug trends.